Amanote Research
Register
Sign In
Radiotherapy May Sensitize to CTLA4 Blockade in Patients With NSCLC
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2018-204
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
November 21, 2018
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
CTLA4 Blockade Increases Th17 Cells in Patients With Metastatic Melanoma
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Ginkgo May Sensitize Ovarian Cancer Cells to Cisplatin
Integrative Cancer Therapies
Oncology
Alternative Medicine
Complementary
P2.01-127 Efficacy of Endostar Combined With Whole Brain Radiotherapy in Patients With NSCLC Brain Metastases
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Fludarabine Combined With Radiotherapy in Patients With Locally Advanced NSCLC Lung Carcinoma: A Phase I Study
Journal of Cancer Research and Clinical Oncology
Medicine
Cancer Research
Oncology
MA19.09 Concurrent Mutations in STK11 and KEAP1 Is Associated With Resistance to PD-(L)1 Blockade in Patients With NSCLC Despite High TMB
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Influence of Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA4) Common Polymorphisms on Outcome in Treatment of Melanoma Patients With CTLA-4 Blockade
Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer Research
Allergy
Immunology
Pharmacology
P2.01-21 Antigen Cascade Triggering Correlates With Prolonged Survival in Advanced NSCLC Patients Undergone PD-1 Blockade With Nivolumab.
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Using Immmunotherapy to Target EGF in Patients With NSCLC
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
P3.16-17 Cardiac Sparing in Stereotactic Body Radiotherapy of Early Stage NSCLC Patients
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
